As tobacco companies aggressively expand into the alternative products market, their main challenge remains earning credibility. "We know that cigarettes are dangerous and addictive," said William F. "Billy" Gifford, CEO of Altria, in a recent speech to the Richmond Chamber of Commerce. "And we know that society's first expectation of us is to reduce the harm associated with cigarettes.
After serving as Vice Chairman and Chief Financial Officer in various leadership positions at the company, Billy Gifford became CEO of Altria in April 2020. He noted that focusing on safer alternatives is logical. "Therefore, it makes sense for us to focus resources on alternatives to quitting smoking for adult smokers who cannot or do not want to quit smoking.
Switching from cigarettes to safer alternatives.
In recent years, Altria has made various investments to shift its focus from cigarettes to safer alternatives. In 2021, the company spent $372 million to acquire a Swiss-based manufacturer of smokeless, oral nicotine products that are currently sold in the United States under the On! brand.
Meanwhile, competitor British American Tobacco (BATS.L) recently announced a 7% increase in adjusted revenue for the year, with dividend growth of 1.0% to 217.8p, and the implementation of a £2 billion share buyback plan in 2022.
The tobacco company also reported a 51% increase in sales for its "next generation" product line, reaching £2.05 billion, which includes e-cigarettes, heated tobacco, and oral nicotine products. Despite the division not yet generating any profits, BAT said it aims to report revenue and profitability of £5 billion by 2025.
The continued growth of the new category is the cornerstone of BAT's long-term success plan," said analyst Ross Hindle of Third Bridge. "With over 1.1 billion smokers still using combustible products, the opportunity to convert consumers to the new category is highly attractive.
Statement:
This article is compiled from third-party information and is only intended for industry exchange and learning purposes.
This article does not represent the views of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of the article's content. The translation of this article is solely for industry communication and research purposes.
Due to limitations in translation proficiency, the translated article may not fully capture the original meaning. Please refer to the original article for accuracy.
2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements or positions.
The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
